Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) Gross Profit (2016 - 2025)

Historic Gross Profit for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $864000.0.

  • InspireMD's Gross Profit rose 10869.57% to $864000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 2568.09%. This contributed to the annual value of $1.5 million for FY2024, which is 1665.74% down from last year.
  • According to the latest figures from Q3 2025, InspireMD's Gross Profit is $864000.0, which was up 10869.57% from $313000.0 recorded in Q2 2025.
  • InspireMD's 5-year Gross Profit high stood at $864000.0 for Q3 2025, and its period low was $92000.0 during Q3 2021.
  • In the last 5 years, InspireMD's Gross Profit had a median value of $331000.0 in 2024 and averaged $350157.9.
  • Data for InspireMD's Gross Profit shows a peak YoY increase of 31833.33% (in 2021) and a maximum YoY decrease of 6912.75% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows InspireMD's Gross Profit stood at $294000.0 in 2021, then tumbled by 32.65% to $198000.0 in 2022, then soared by 155.05% to $505000.0 in 2023, then decreased by 7.13% to $469000.0 in 2024, then surged by 84.22% to $864000.0 in 2025.
  • Its Gross Profit stands at $864000.0 for Q3 2025, versus $313000.0 for Q2 2025 and $292000.0 for Q1 2025.